- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06044012
Buccal Myomucosal Flap and Buccal Pad of Fat for the Closure of Oro-antral Fistula
September 12, 2023 updated by: Ahmed Abdellatif Abdelfatah, Tanta University
Double Layer of Buccal Myomucosal Flap and Buccal Pad of Fat for the Closure of Large Oro-antral Fistula
Oroantral fistula (OAF) is a pathological communication between the oral cavity and the maxillary sinus.
A variety of surgical techniques have been developed, with recurrence rates of up to 33%7, mainly due to wound contraction and postoperative infection.
To increase the success rates of OAF closure procedures, the use of double-layered closure techniques has developed, but most of these techniques alter the original oral anatomy and may result in significant postoperative morbidity.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ahmed A Mosleh, PhD
- Phone Number: 0201094279620
- Email: ahmed_mosleh@dent.tanta.edu.eg
Study Locations
-
-
-
Tanta, Egypt, 31773
- Recruiting
- Faculty of Dentistry, Tanta University
-
Contact:
- Ahmed A AbdEllatif, PhD
- Phone Number: 01094279620
- Email: drahmed_maxillofacial@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Large Oro-antral Fistula
- Recent or previously failed closure of oro-antral Fistula
Exclusion Criteria:
- Immuno-supressed patients
- fistulae smaller than 5 mm in size
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients with large Oro-antral Fistula
closure of oro-antral fistula by myomucosal flap and buccal pad of fat
|
The buccal myomucosal flap will be harvested from cheek below stenson papilla and will be sutured over buccal pad of fat which will be sutured at palatal mucosa after complete curettage of infected fistulous tract.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Healing
Time Frame: 6 months
|
The size of fistula will be clinically measured by digital caliper in centimeter for preoperative and postoperative for uneventful wound healing and disappearance of fistula .
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
infection
Time Frame: 6 months
|
fluid level will be measured in cubic centimeter in computed tomography
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2023
Primary Completion (Estimated)
December 1, 2023
Study Completion (Estimated)
December 1, 2023
Study Registration Dates
First Submitted
May 8, 2023
First Submitted That Met QC Criteria
September 12, 2023
First Posted (Actual)
September 21, 2023
Study Record Updates
Last Update Posted (Actual)
September 21, 2023
Last Update Submitted That Met QC Criteria
September 12, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- #R-OS-1-23-3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oro-Antral Communication
-
October 6 UniversityCompleted
-
Uppsala UniversityUnknown
-
Assistance Publique - Hôpitaux de ParisCompletedFertility | Antral Follicle DeficitFrance
-
Lionel BouvetCompleted
-
Assiut UniversityNot yet recruitingGAVE - Gastric Antral Vascular Ectasia
-
H. Lee Moffitt Cancer Center and Research InstituteColumbia University; University Hospitals Cleveland Medical Center; Geisinger... and other collaboratorsSuspendedBleeding | GAVE - Gastric Antral Vascular Ectasia | Bleeding GastricUnited States
-
Cairo UniversityCompletedOral Habits | Oro-Facial DysfunctionEgypt
-
Insel Gruppe AG, University Hospital BernSwiss National Science Foundation; University of Bern; Fachhochschule NordwestschweizRecruitingCommunication Research | Communication, MultidisciplinarySwitzerland
-
Johns Hopkins UniversityCompletedCommunication | Obstetric Complication | High Risk Pregnancy | Multidisciplinary CommunicationUnited States
Clinical Trials on Double layer of buccal myomucosal Flap and buccal pad of fat
-
Cairo UniversityNot yet recruiting
-
Marwa Taha IbrahimCompleted
-
October 6 UniversityCompleted
-
Region GävleborgMalmö University; Swedish Dental Associations Scientific Funds; Department of... and other collaboratorsCompletedOrthodontic Anchorage Procedures | Orthodontic Space ClosureSweden
-
Alexandria UniversityActive, not recruitingAnesthesia, LocalEgypt
-
Istituto Ortopedico RizzoliCompletedExostoses, Multiple HereditaryItaly
-
BioDelivery Sciences InternationalCompletedPain | Low Back PainUnited States
-
Vanderbilt University Medical CenterNational Institute on Drug Abuse (NIDA)RecruitingPain | Analgesia | Abuse OpioidsUnited States
-
Generex Biotechnology Corp.No longer availableType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus
-
University GhentCompletedGuided Bone Regeneration